Related to GE Healthcare, Affibody to Develop Her2 Imaging Agent for Breast, Gastric Cancers

• Roche to Plug Over $181M Into Manufacturing Sites to Produce Self-Administration Device for Herceptin
  
• Repligen Strikes Five-Year Extension to Supply Protein A to GE Healthcare
  
• CardioDx Scores $5M from GE Healthcare to Co-Develop Cardiovascular Disease Tests
  
• GE Healthcare Grants Green Fluorescent Protein Technology Rights to Taconic
  
• GE and Memorial Sloan-Kettering Team Up to Study Early-Stage Colon Cancer
  
• G-Con and GE Healthcare Team Up for Modular Biotherapeutic Manufacturing Solution
  
• GE Healthcare Acquires Cell Imaging Firm Applied Precision
  
• GE Healthcare to Provide Customers with On-Site Service and Support for AB Sciex Mass Spec Systems
  
• Sartorius Stedim and GE Healthcare Cross-License Biomanufacturing IP
  
• GE Healthcare, M+W to Bolster Biomanufacturing in Emerging Nations
  
• GE Healthcare Supplies Refine Tech with Filtration Cartridges for ATF Cell Retention System
  
• GE Healthcare, Karolinska University Ally to Enable Routine Application of Cell Therapies
  
• Genentech Plans 2012 U.S./EU Filing for T-DM1 in Metastatic Her2 Breast Cancer
  
• GE Healthcare, BGI Explore Stem Cell Genetics with a View to Drug Discovery Assays
  
• Galena and Leica to Develop CDx for Breast Cancer Therapeutic
  
• GE Healthcare to Market Fujifilm Image-Analysis Platforms Worldwide
  
• Algeta Signs Deal to Combine Thorium Platform with Affibody’s Tumor-Targeting Molecules
  
• Ipsen Pays PhotoCure and GE Healthcare €19M for Commercialization Rights to Hexvix
  
• Odyssey Thera to Use GE Healthcare’s Imaging System
  
• GE Healthcare, Dyax to Develop c-Met Imaging Peptides for Cancer